Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Disposition to Issuer of 1,093,803 CPRX shares, $34.45M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Disposition to Issuer | 1,093,803 | $34.45M |
| Dec 30, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 14,000 | n/a |
| Dec 10, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 11,873 | n/a |
| Nov 25, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 8,267 | n/a |
| Aug 28, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 115,000 | $257.6K |
| Feb 19, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 13,667 | n/a |
| Dec 31, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 14,000 | n/a |
| Dec 17, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 235,000 | $942.4K |
| Dec 11, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Exercise/Conversion | 11,872 | n/a |
| Nov 25, 2024 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Grant/Award | 202,958 | n/a |